WCBA
MD icon

Weaver C. Barksdale & Associates’s Pediatrix Medical MD Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$20K Sell
365
-35
-9% -$1.65K 0.02% 160
2017
Q3 		$17K Buy
400
+95
+31% +$4.51K 0.02% 175
2017
Q2 		$18K Buy
305
+66
+28% +$3.91K 0.02% 168
2017
Q1 		$17K Sell
239
-27
-10% -$1.88K 0.02% 179
2016
Q4 		$18K Buy
266
+45
+20% +$2.93K 0.03% 171
2016
Q3 		$15K Buy
221
+21
+11% +$1.44K 0.03% 187
2016
Q2 		$14K Sell
200
-31,998
-99% -$2.2M 0.02% 177
2016
Q1 		$2.08M Buy
32,198
+24
+0.1% +$1.59K 1.56% 30
2015
Q4 		$2.31M Buy
32,174
+21
+0.1% +$1.55K 1.8% 28
2015
Q3 		$2.47M Buy
32,153
+31,994
+20,122% +$2.58M 1.99% 25
2015
Q2 		$12K Buy
159
+10
+7% +$720 0.01% 241
2015
Q1 		$11K Hold
149
– – 0.01% 264
2014
Q4 		$10K Sell
149
-38
-20% -$2.32K 0.01% 274
2014
Q3 		$10K Buy
187
+22
+13% +$1.25K 0.01% 264
2014
Q2 		$10K Buy
165
+17
+11% +$1K 0.01% 277
2014
Q1 		$9K Buy
148
+69
+87% +$4.01K 0.01% 284
2013
Q4 		$4K Sell
79
-79
-50% -$4.24K ﹤0.01% 415
2013
Q3 		$8K Sell
158
-12
-7% -$586 0.01% 308
2013
Q2 		$8K Buy
+170
New +$7.61K 0.01% 306

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Weaver C. Barksdale & Associates's MD Position: Q4 2017 in Review

Weaver C. Barksdale & Associates reduced its Pediatrix Medical (MD) stake by 8.8% in Q4 2017, selling an estimated $1.65K and leaving 365 shares worth $20K. The position accounts for 0.02% of the portfolio, ranked #160.

Weaver C. Barksdale & Associates first reported a position in MD in Q2 2013 and has held it in 19 quarters since. The position peaked at $2.47M in Q3 2015. 330 funds tracked by Wall St. Rank hold MD as of Q4 2017.

  • Weaver C. Barksdale & Associates held 365 shares of Pediatrix Medical worth $20K as of Q4 2017.
  • Weaver C. Barksdale & Associates sold 35 Pediatrix Medical shares in Q4 2017, an estimated $1.65K.
  • Pediatrix Medical made up 0.02% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #160 holding.
  • Weaver C. Barksdale & Associates first reported a position in Pediatrix Medical in Q2 2013 and has held it in 19 quarters since.
  • Weaver C. Barksdale & Associates's Pediatrix Medical position peaked at $2.47M in Q3 2015.
  • 330 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.